Caberoline 0.5mg

Targeted Treatment for Hyperprolactinemia and Related Disorders
Cabergoline 0.5mg, containing the potent dopamine receptor agonist Cabergoline, is a first-line medical therapy for conditions caused by excessive production of prolactin (hyperprolactinemia). By mimicking the action of dopamine in the brain, it directly inhibits the secretion of prolactin from the pituitary gland, effectively normalizing hormone levels and alleviating the associated symptoms.

Primary Medical Indications:

• Hyperprolactinemia: Treatment of idiopathic or tumor-related (prolactinoma) high prolactin levels.

• Prolactin-Secreting Adenomas: Management of benign pituitary tumors that produce excess prolactin, often reducing tumor size.

• Restoration of Ovarian & Testicular Function: Corrects infertility, irregular menstruation, and low testosterone caused by prolactin suppression of gonadotropin release.

• Galactorrhea: Stops inappropriate or persistent milk production not related to childbirth or nursing.

• Parkinson’s Disease: Used at higher doses as an adjunctive treatment (though the 0.5mg strength is typically for endocrine disorders).

Dosing, Efficacy, and Key Advantages
Cabergoline is favored for its long duration of action and generally favorable side effect profile compared to older medications in its class.

• Dosage: Treatment usually begins at a low dose, such as 0.25mg twice per week, with the 0.5mg tablet allowing for precise splitting or dose escalation. The dose is gradually adjusted based on prolactin level response, often reaching a maintenance dose of 0.5mg to 1mg per week.

• Convenience: Its long half-life allows for once- or twice-weekly dosing, improving patient compliance.

• Tumor Reduction: Can effectively shrink prolactin-secreting pituitary macroadenomas and microadenomas.

Important Safety Information and Side Effects
Cabergoline is a potent medication. It is contraindicated in women who are or may become pregnant unless clearly necessary and with strict monitoring.

• Cardiovascular Monitoring: Long-term, high-dose use (primarily in Parkinson’s disease) has been associated with an increased risk of cardiac valvulopathy. For hyperprolactinemia doses, this risk is considered low, but baseline and periodic echocardiogram monitoring may be recommended by your physician.

• Common Side Effects: Include nausea, dizziness, headache, fatigue, constipation, and orthostatic hypotension (lightheadedness when standing up). These often diminish with continued use.

• Behavioral Effects: Dopamine agonists have been associated with impulse control disorders, such as pathological gambling, binge eating, compulsive shopping, and increased libido. Patients should be monitored for these behaviors.

• Pregnancy: If pregnancy is desired, the goal is to use the lowest effective dose to normalize prolactin and restore ovulation. Once pregnant, Cabergoline is typically discontinued due to limited safety data, though studies have not shown increased malformation rates.

Product Specifications:

• Active Ingredient: Cabergoline (0.5mg per tablet)

• Form: Oral Tablet (often scored for easy splitting)

• Typical Packaging: Blister packs, commonly containing 8 tablets (a month’s supply at a typical starting dose).

• Storage: Store at room temperature, protected from light and moisture.

• Prescription Required: YES – A valid prescription from an endocrinologist or other qualified specialist is mandatory.

A Cornerstone of Endocrine Management
When used appropriately under specialist care, Cabergoline 0.5mg is a highly effective and well-tolerated treatment that can normalize hormone levels, restore fertility, and manage prolactinoma growth, significantly improving a patient’s quality of life.

Professional Diagnosis is Essential
Symptoms of high prolactin can mimic other conditions. A proper diagnosis through blood tests and often a pituitary MRI is required before starting treatment. Management with Cabergoline should be overseen by an endocrinologist who can tailor the dose and conduct necessary monitoring.